Literature DB >> 18032388

Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy.

Audrey Fischer1, Consuelo Garcia-Rodriguez, Isin Geren, Jianlong Lou, James D Marks, Terunaga Nakagawa, Mauricio Montal.   

Abstract

Clostridial botulinum neurotoxin (BoNT) causes a neuroparalytic condition recognized as botulism by arresting synaptic vesicle exocytosis. Although the crystal structures of full-length BoNT/A and BoNT/B holotoxins are known, the molecular architecture of the five other serotypes remains elusive. Here, we present the structures of BoNT/A and BoNT/E using single particle electron microscopy. Labeling of the particles with three different monoclonal antibodies raised against BoNT/E revealed the positions of their epitopes in the electron microscopy structure, thereby identifying the three hallmark domains of BoNT (protease, translocation, and receptor binding). Correspondingly, these antibodies selectively inhibit BoNT translocation activity as detected using a single molecule assay. The global structure of BoNT/E is strikingly different from that of BoNT/A despite strong sequence similarity. We postulate that the unique architecture of functionally conserved modules underlies the distinguishing attributes of BoNT/E and contributes to differences with BoNT/A.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032388     DOI: 10.1074/jbc.M707917200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells.

Authors:  Heather K Kroh; Ramyavardhanee Chandrasekaran; Zhifen Zhang; Kim Rosenthal; Rob Woods; Xiaofang Jin; Andrew C Nyborg; G Jonah Rainey; Paul Warrener; Roman A Melnyk; Benjamin W Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

Review 2.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 3.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

Review 4.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

Review 5.  Assembly and function of the botulinum neurotoxin progenitor complex.

Authors:  Shenyan Gu; Rongsheng Jin
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

6.  Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays.

Authors:  Yanfeng Zhang; Jianlong Lou; Kathy L Jenko; James D Marks; Susan M Varnum
Journal:  Anal Biochem       Date:  2012-08-27       Impact factor: 3.365

Review 7.  Unique ganglioside binding by botulinum neurotoxins C and D-SA.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

8.  Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.

Authors:  C Garcia-Rodriguez; I N Geren; J Lou; F Conrad; C Forsyth; W Wen; S Chakraborti; H Zao; G Manzanarez; T J Smith; J Brown; W H Tepp; N Liu; S Wijesuriya; M T Tomic; E A Johnson; L A Smith; J D Marks
Journal:  Protein Eng Des Sel       Date:  2010-12-13       Impact factor: 1.650

Review 9.  Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel.

Authors:  Mauricio Montal
Journal:  Toxicon       Date:  2008-12-14       Impact factor: 3.033

10.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.